579 Phase I and Pharmacokinetic (PK) Study of Pazopanib in Combination with Two Schedules of Docetaxel (D) in Patients (pts) with Advanced Solid Tumors

Authors :: Walter J. Loos
P. Hamberg
D. van der Biessen
Stefan Sleijfer
Ron H.J. Mathijssen
P. de Bruijn
Jaap Verweij
M.J.A. de Jonge
Source :: European Journal of Cancer. 48:177
Publication Year :: 2012
Publisher :: Elsevier BV, 2012.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
Pazopanib
Docetaxel
Pharmacokinetics
Internal medicine
Phase (matter)
Medicine
In patient
business
medicine.drug

Full Text Access

Tools